Authors: AMCHIN J ZARYCRANSKI W TAYLOR K

Citation: J. Amchin et al., EFFECT OF VENLAFAXINE ON THE PHARMACOKINETICS OF RISPERIDONE, Psychopharmacology bulletin, 33(3), 1997, pp. 491-491

Authors: AMCHIN J ZARYCRANSKI W TAYLOR K

Citation: J. Amchin et al., VENLAFAXINES LACK OF CYP3A4 INHIBITION ASSESSED BY TERFENADINE METABOLISM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 56-56

Authors: AMCHIN J ZARYCRANSKI W TAYLOR K

Citation: J. Amchin et al., EVIDENCE THAT VENLAFAXINE DOES NOT INHIBIT CYP1A2 AS MEASURED IN-VIVOBY THE METABOLISM OF CAFFEINE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 57-57

Authors: AMCHIN J ZARYCRANSKI W

Citation: J. Amchin et W. Zarycranski, EFFECT OF VENLAFAXINE ON THE PHARMACOKINETICS OF ALPRAZOLAM, Psychopharmacology bulletin, 32(3), 1996, pp. 410-410

Authors: ERESHEFSKY L AMCHIN J ZARYCRANSKI W HEATH G

Citation: L. Ereshefsky et al., RELATIONSHIP OF PLASMA-CONCENTRATIONS OF FLUOXETINE AND VENLAFAXINE WITH EFFECTS ON CYP2D6 IN-VIVO, Psychopharmacology bulletin, 32(3), 1996, pp. 440-440